Feixiang Bao

Prof. Feixiang Bao

Guangzhou Institutes of Biomedicine and Health, Chinese Academyof Sciences, Guangzhou, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2022 in Science Advances
Verified
Journal Article
Open access
Feixiang BaoFeixiang Bao
Feixiang Bao
LZLingyan Zhou
Lingyan Zhou
RZRui Zhou
Rui Zhou
QHQiaoying Huang
Qiaoying Huang
JCJunguo Chen
Junguo Chen
Xingguo LiuXingguo Liu
Xingguo Liu
Mitochondrial quality control plays an important role in maintaining mitochondrial homeostasis and function. Disruption of mitochondrial quality control degrades brain function. We found that flunarizine (FNZ), a drug whose chronic use causes parkinsonism, led to a parkinsonism-like motor dysfunction in mice. FNZ induced mitochondrial dysfunction and decreased mitochondrial mass specifically in the brain. FNZ decreased mitochondrial content in both neurons and astrocytes, without affecting the number of nigral dopaminergic neurons. In human neural progenitor cells, FNZ also induced mitochondrial depletion. Mechanistically, independent of ATG5- or RAB9-mediated mitophagy, mitochondria were engulfed by lysosomes, followed by a vesicle-associated membrane protein 2– and syntaxin-4–dependent extracellular secretion. A genome-wide CRISPR knockout screen identified genes required for FNZ-induced mitochondrial elimination. These results reveal not only a previously unidentified lysosome-associated exocytosis process of mitochondrial quality control that may participate in the FNZ-induced parkinsonism but also a drug-based method for generating mitochondria-depleted mammal cells.

15 April 2016 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Closed access
PDF file
Feixiang BaoFeixiang Bao
Feixiang Bao
HSHong‐Yan Shi
Hong‐Yan Shi
QLQi Long
Qi Long
LYLiang Yang
Liang Yang
YWYi Wu
Yi Wu
Xingguo LiuXingguo Liu
Xingguo Liu

20 September 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
Feixiang BaoFeixiang Bao
Feixiang Bao
HSHongyan Shi
Hongyan Shi
MGMi Gao
Mi Gao
LYLiang Yang
Liang Yang
LZLingyan Zhou
Lingyan Zhou
Xingguo LiuXingguo Liu
Xingguo Liu
Hexadimethrine bromide (Polybrene) was once used clinically as a heparin neutralizer and has recently found use as a promoter in virus-mediated gene therapy trials and gene transfer in research. However, the potential for tissue-specific toxicity of polybrene at low doses has been ignored so far. Here, we found that after intracerebroventricular (ICV) polybrene injection, mice showed disability of movement accompanied neural death and gliosis in brain, and in human neurons, polybrene induces concentration-dependent neuritic beading and fragmentation. Mechanistically, polybrene induces a rapid voltage-dependent calcium channel (VDCC)-mediated influx of extracellular Ca2+. The elevated cytoplasmic Ca2+ activates DRP1, which leads to mitochondrial fragmentation and metabolic dysfunction. At the same time, Ca2+ influx induces endoplasmic reticulum (ER) fragmentation and tightened associations between ER and mitochondria, which makes mitochondria prone to Ca2+ overloading and ensuing permeability transition. These results reveal an unexpected neuronal toxicity of polybrene, wherein Ca2+ influx serves as a regulator for both mitochondrial dynamics and ER–mitochondrial remodeling.

8 August 2024 in Science China Life Sciences
Verified
Journal Article
Closed access
PDF file
RWRui Wang
Rui Wang
Feixiang BaoFeixiang Bao
Feixiang Bao
MLManjiao Lu
Manjiao Lu
XJXiaoyun Jia
Xiaoyun Jia
JXJiahui Xiao
Jiahui Xiao
Xingguo LiuXingguo Liu
Xingguo Liu

24 October 2025 in Science Advances
Verified
Journal Article
Open access
YMYanmei Ma
Yanmei Ma
WHWeikang Hu
Weikang Hu
MRMuyang Ruan
Muyang Ruan
Feixiang BaoFeixiang Bao
Feixiang Bao
Xingguo LiuXingguo Liu
Xingguo Liu
Chengzhi HuChengzhi Hu
Chengzhi Hu
Robotic micromanipulation has advanced cellular probing, yet achieving precise, minimally invasive intracellular operations without fluorescent labeling remains challenging. Fluorescent techniques often cause photodamage and cytotoxicity and interfere with downstream analyses. Here, we introduce an automated, multifunctional nanoprobing platform capable of label-free extraction of mitochondria from living cells with high spatiotemporal resolution. The nanoprobe integrates two individually addressable nanoelectrodes that perform electrochemical detection of reactive oxygen and nitrogen species, produced by mitochondrial metabolism, followed by dielectrophoretic trapping, manipulation, and extraction of mitochondria. We successfully demonstrated the extraction of mitochondria from living cells, which is validated through fluorescence labeling before and after extraction. Subsequent quantitative polymerase chain reaction further confirmed that the extracted sample contained mitochondria. The fusion of the transplanted mitochondria within the recipient cell’s mitochondrial network confirms their activity. This automated, label-free, in situ organelle extraction micromanipulation system offers a powerful tool for understanding disease mechanisms linked to dysfunctional organelles and enables single-cell surgeries for organelle transplantation.

3 June 2025 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
LZLingyan Zhou
Lingyan Zhou
Feixiang BaoFeixiang Bao
Feixiang Bao
JZJiajun Zheng
Jiajun Zheng
YDYingzhe Ding
Yingzhe Ding
JXJiahui Xiao
Jiahui Xiao
Xingguo LiuXingguo Liu
Xingguo Liu